Cancer Clinical Trial
Official title:
DELI-DEVI : Determinants of End-of-life Place of Care for Children Suffering From Cancer.
Cancer is the second cause of over-one-year-old children mortality after accident. Survival
rate is more than 70%, but in some cases, curative treatments are not sufficient and
palliative support is implemented for those children in end of life.
Pediatric guidelines about the place of end-of-life care are varied. On European scale, home
is recommended (IMPaCCT study, 2007). In France, the 2008-2012 palliative care development
program recommended home or initial hospital care unit. This program also supports
implementation of mobile team rather than specific hospital units.
In Brittany, a pattern of regional palliative care resource team has been implemented since
2005. In oncology, further to the guidelines, end-of-life place of care is often discussed
several times for each case. Sometimes occur a lot of returns between home and hospital,
psychological difficulties, and difficulties to offer adapted care conditions. Finally, less
than 30% of children in palliative care decease at home.
The primary objective is to identify main determinants of the place of palliative care in
pediatric oncology.
The secondary objective is to clarify the factors of change comparing to the initial planned
place.
Intervention :
Questionnaire completed by the parents Interview with the parents and the psychologist
(University Rennes 2)
Number of subjects is : Parents of 68 to 93 children who died from cancer after a palliative
phase, that means 136 to 186 parents.
Expected results and perspectives :
Using both quantitative and qualitative methods, expected results are the followings:
- Identification of the objective and subjective factors, which influenced the decision
of the place of care.
- Determination of the factors of change comparing to the initial planned place.
Once identified, main factors could be the ones to pay attention to in order to help for
initial decision, better anticipation of change of place and better guidance of palliative
care organization wherever, at home or in hospital.
Results would be new information for research on palliative care for children but also for
adults.
Finally, this work is part of an improving approach of palliative care, related to the
development of open-care hospital networks. We can expect some public health impacts with
new arguments to help for complementary recommendations.
Eligibility criteria :
Inclusion criteria are :
Parents of a deceased child
- From cancer, after palliative phase
- Age of death under 18 years old.
- Death occurred in Brittany
- Death between 2005 and 2010
Exclusion criterium is :
Parents of child who deceased after 2010 (respecting a bereavement delay)
Outcomes measures :
Primary study endpoint : Consideration or not by parents that they and/or their child had
the choice of the end-of-life place of care.
Secondary study endpoints :
- objective factors : grade, occupational categories, marital status of parents,
siblings, home conditions, access to the hospital, meeting with a professional of
palliative care network, helpful general practitioner, volunteers, psychological
support but also unexpected symptoms, needed nursing care which can explain a return
from home to hospital for instance.
- subjective factors such as family or religious values, needs of intimacy,
communication, support, sense of security, anxiety, fear, doubts about the next events.
;
Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|